Company
Adverum Biotechnologies, Inc. (0001501756)
Standardized SEC financial data for Adverum Biotechnologies, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001501756 · Biological Products, (No Diagnostic Substances).
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-72.2%
Return on equity
-185.2%
Free cash flow
-$92.8M
Current ratio
5.73×
EPS (diluted)
$-6.62
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $7.5M | $7.5M | $0 | $3.6M | $1.0M |
| R&D expense |
Balance sheet
| USD | FY2023 | FY2023 | FY2024 | FY2024 | FY2024 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $105.4M | $96.5M | $149.6M | $127.3M | $92.9M | $125.7M |
| Total current assets |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$49.2M | -$79.3M | -$107.8M | -$108.1M | -$90.9M | -$92.5M |
| Capital expenditures |
Get 0001501756 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001501756/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001501756/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"